Dismiss
Due to holidays in some regions, we will not send a daily email alert Monday May 29. Our normal daily alerts resume May 30.
Acturum Life Sciences AB
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Acturum Life Sciences AB
AlzeCure Confident Of Bagging Partner For Pain Drug
Bookmark
-
News
The Swedish biotech is stepping up its business development plans ahead of a mid-stage readout in the summer for ACD440, its TRPV1 antagonist for neuropathic pain.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
Advertisement
Advertisement
Acturum Life Sciences AB
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice